AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 70 filers reported holding AUTOLUS THERAPEUTICS PLC in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $69,485 | +7.3% | 29,822 | +9.6% | 0.00% | +100.0% |
| Q2 2023 | $64,772 | +29.3% | 27,215 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $50,076 | -3.2% | 27,215 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $51,709 | -10.8% | 27,215 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $58,000 | -36.3% | 27,215 | -15.4% | 0.00% | -50.0% |
| Q2 2022 | $91,000 | -41.3% | 32,178 | -13.4% | 0.00% | -50.0% |
| Q1 2022 | $155,000 | -47.8% | 37,171 | -35.0% | 0.00% | -42.9% |
| Q4 2021 | $297,000 | -53.0% | 57,143 | -40.7% | 0.01% | -58.8% |
| Q3 2021 | $632,000 | -50.4% | 96,424 | -49.7% | 0.02% | -58.5% |
| Q2 2021 | $1,274,000 | +48.3% | 191,820 | +28.0% | 0.04% | +28.1% |
| Q1 2021 | $859,000 | +226.6% | 149,912 | +1773.9% | 0.03% | -15.8% |
| Q4 2018 | $263,000 | – | 8,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 21,346,829 | $49,738,112 | 74.10% |
| TFG Asset Management GP Ltd | 12,000,000 | $27,960,000 | 5.10% |
| Paradigm Biocapital Advisors LP | 14,406,782 | $33,567,802 | 2.28% |
| Lynx1 Capital Management LP | 1,363,025 | $3,175,848 | 2.10% |
| Deep Track Capital, LP | 15,000,000 | $34,950,000 | 1.35% |
| Affinity Asset Advisors, LLC | 1,992,466 | $4,642,446 | 1.31% |
| DAFNA Capital Management LLC | 928,253 | $2,162,829 | 0.67% |
| Frazier Life Sciences Management, L.P. | 3,746,857 | $8,730,177 | 0.58% |
| ARMISTICE CAPITAL, LLC | 6,900,000 | $16,077,000 | 0.25% |
| Blackstone Inc. | 20,485,611 | $47,731,474 | 0.20% |